These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23575274)

  • 1. A poor drug-resistant tuberculosis programme is worse than no programme: time for a change.
    Chiang CY; Van Deun A; Enarson DA
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):714-8. PubMed ID: 23575274
    [No Abstract]   [Full Text] [Related]  

  • 2. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 3. Is this the time to revise the Revised National Tuberculosis Control Programme in India?--yes and no..
    Jindal SK; Agarwal R
    Natl Med J India; 2008; 21(4):159-62. PubMed ID: 19267034
    [No Abstract]   [Full Text] [Related]  

  • 4. European expansion. Outwitting TB on the E.U.'s eastern frontier.
    Enserink M
    Science; 2004 Apr; 304(5668):199. PubMed ID: 15073353
    [No Abstract]   [Full Text] [Related]  

  • 5. Programmatic management of multidrug-resistant tuberculosis--15 years later.
    Nardell EA
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1280. PubMed ID: 22283883
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
    Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing drug-resistant tuberculosis: experiences from India.
    Katoch VM
    Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676
    [No Abstract]   [Full Text] [Related]  

  • 8. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-resistant tuberculosis: how are we doing?
    Reichman LB; Lardizabal A
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):711. PubMed ID: 23676151
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis in childhood.
    Shingadia D
    Ther Adv Respir Dis; 2012 Jun; 6(3):161-71. PubMed ID: 22361927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area.
    van der Werf MJ; Sandgren A; Manissero D
    Int J Tuberc Lung Dis; 2012; 16(3):426. PubMed ID: 22640458
    [No Abstract]   [Full Text] [Related]  

  • 12. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 13. Break through multidrug-resistant TB.
    Gribble EA; Williams A
    Nurse Pract; 2010 Mar; 35(3):14-22; quiz 22-3. PubMed ID: 20164730
    [No Abstract]   [Full Text] [Related]  

  • 14. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiology of multi-drug resistant tuberculosis in AIDS].
    Moro ML
    Recenti Prog Med; 1999 Oct; 90(10):515-21. PubMed ID: 10592736
    [No Abstract]   [Full Text] [Related]  

  • 16. Multi drug resistant tuberculosis.
    Dey AB; Nagarkar K
    Trop Gastroenterol; 1995; 16(2):92-100. PubMed ID: 8644369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 20. The Russian equation: an evolving paradigm in tuberculosis control.
    Kimerling ME
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S160-7. PubMed ID: 11144547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.